Hereditary breast and ovarian cancer [NEW TOPIC PAGE]

PubMed Clinical Queries



From PubMed Clinical Queries

PubMed Clinical Queries is an utility offered by PubMed to search scientific literature in specific clinical research areas

---

• Search PubMed Clinical Queries for "Hereditary breast and ovarian cancer" 

Results: 5 of 212

• Promoting guideline-based cancer genetic risk assessment for hereditary breast and ovarian cancer in ethnically and geographically diverse cancer survivors: Rationale and design of a 3-arm randomized controlled trial.
  Kinney AY, Howell R, Ruckman R, McDougall JA, Boyce TW, Vicuña B, Lee JH, Guest DD, Rycroft R, Valverde PA, et al.Contemp Clin Trials. 2018 Sep 18; 73:123-135. Epub 2018 Sep 18.
• Modifiable Lifestyle Factors: Opportunities for (Hereditary) Breast Cancer Prevention - a Narrative Review.
  Lammert J, Grill S, Kiechle M.Breast Care (Basel). 2018 Apr; 13(2):109-114. Epub 2018 Apr 20.
• [Molecular Targeted Therapies for Hereditary Cancer Syndrome].
  Shimodaira H.Gan To Kagaku Ryoho. 2018 Apr; 45(4):587-592.
• Outcome after neoadjuvant chemotherapy in elderly breast cancer patients - a pooled analysis of individual patient data from eight prospectively randomized controlled trials.
  von Waldenfels G, Loibl S, Furlanetto J, Machleidt A, Lederer B, Denkert C, Hanusch C, Kümmel S, von Minckwitz G, Schneeweiss A, et al.Oncotarget. 2018 Mar 16; 9(20):15168-15179. Epub 2018 Feb 26.
• Crosstalk of DNA double-strand break repair pathways in poly(ADP-ribose) polymerase inhibitor treatment of breast cancer susceptibility gene 1/2-mutated cancer.
  Sunada S, Nakanishi A, Miki Y.Cancer Sci. 2018 Apr; 109(4):893-899. Epub 2018 Mar 6.

See all (212)

This column displays citations filtered to a specific clinical study category and scope. These search filters were developed by Haynes RB et al. See more filter information.

Systematic Reviews

Results: 5 of 75

• A Systematic Review of How Young People Live with Inherited Disease: What Can We Learn for Li-Fraumeni Syndrome?
  Forbes Shepherd R, Lewis A, Keogh LA, Werner-Lin A, Delatycki MB, Forrest LE.J Adolesc Young Adult Oncol. 2018 Jul 13; . Epub 2018 Jul 13.
• A systematic review on the frequency of BRCA promoter methylation in breast and ovarian carcinomas of BRCA germline mutation carriers: Mutually exclusive, or not?
  Vos S, van Diest PJ, Moelans CB.Crit Rev Oncol Hematol. 2018 Jul; 127:29-41. Epub 2018 May 14.
• Results of surveillance in individuals at high-risk of pancreatic cancer: A systematic review and meta-analysis.
  Signoretti M, Bruno MJ, Zerboni G, Poley JW, Delle Fave G, Capurso G.United European Gastroenterol J. 2018 May; 6(4):489-499. Epub 2018 Jan 8.
• Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart Data.
  Wunderle M, Olmes G, Nabieva N, Häberle L, Jud SM, Hein A, Rauh C, Hack CC, Erber R, Ekici AB, et al.Geburtshilfe Frauenheilkd. 2018 May; 78(5):481-492. Epub 2018 Jun 4.
• The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice.
  Menko FH, Ter Stege JA, van der Kolk LE, Jeanson KN, Schats W, Moha DA, Bleiker EMA.Fam Cancer. 2018 May 30; . Epub 2018 May 30.

See all (75)

This column displays citations for systematic reviews, meta-analyses, reviews of clinical trials, evidence-based medicine, consensus development conferences, and guidelines. See filter information or additional related sources.

Medical Genetics

Topic:AllDiagnosisDifferential DiagnosisClinical DescriptionManagementGenetic CounselingMolecular GeneticsGenetic Testing

Results: 5 of 2102

• Comprehensive Analysis of Germline Variants in Mexican Patients with Hereditary Breast and Ovarian Cancer Susceptibility.
  Quezada Urban R, Díaz Velásquez CE, Gitler R, Rojo Castillo MP, Sirota Toporek M, Figueroa Morales A, Moreno García O, García Esquivel L, Torres Mejía G, Dean M, et al.Cancers (Basel). 2018 Sep 27; 10(10). Epub 2018 Sep 27.
• Combining Homologous Recombination and Phosphopeptide-binding Data to Predict the Impact of BRCA1 BRCT Variants on Cancer Risk.
  Petitalot A, Dardillac E, Jacquet E, Nhiri N, Guirouilh-Barbat J, Julien P, Bouazzaoui I, Bonte D, Feunteun J, Schnell JA, et al.Mol Cancer Res. 2018 Sep 26; . Epub 2018 Sep 26.
• Dealing With BRCA1/2 Unclassified Variants in a Cancer Genetics Clinic: Does Cosegregation Analysis Help?
  Zuntini R, Ferrari S, Bonora E, Buscherini F, Bertonazzi B, Grippa M, Godino L, Miccoli S, Turchetti D.Front Genet. 2018; 9:378. Epub 2018 Sep 11.
• Population-based genetic testing of asymptomatic women for breast and ovarian cancer susceptibility.
  Rowley SM, Mascarenhas L, Devereux L, Li N, Amarasinghe KC, Zethoven M, Lee JEA, Lewis A, Morgan JA, Limb S, et al.Genet Med. 2018 Sep 26; . Epub 2018 Sep 26.
• Computational Tools for Splicing Defect Prediction in Breast/Ovarian Cancer Genes: How Efficient Are They at Predicting RNA Alterations?
  Moles-Fernández A, Duran-Lozano L, Montalban G, Bonache S, López-Perolio I, Menéndez M, Santamariña M, Behar R, Blanco A, Carrasco E, et al.Front Genet. 2018; 9:366. Epub 2018 Sep 5.

See all (2102)

This column displays citations pertaining to topics in medical genetics. See more filter information.